| Product Information |
|
| Registration Number |
BR-434
|
| Generic Name |
Measles, Mumps and Rubella Vaccine (Live, Attenuated)
|
| Brand Name |
Tresivac
|
| Dosage Strength |
Formulation: After reconstitution, one dose (0.5 mL) contains: Measles Virus-NLT 1,000 CCID 50 Mumps Virus-NLT 5,000 CCID 50 Rubella Virus -NLT 1,000 CCID 50
|
| Dosage Form |
Freeze-dried Powder for Suspension for Injection (SC)
|
| Classification |
Prescription Drug (RX)
|
| Packaging |
Type I amber glass vial + 0.5 mL Type I colourless glass ampoule (Sterile Water for Injection as diluent) (Box of 50s)
|
| Pharmacologic Category |
-
|
| Manufacturer |
Serum Institute of India Private Limited
|
| Country of Origin |
India
|
| Trader |
N/A
|
| Importer |
Genpharm, Inc.
|
| Distributor |
Genpharm, Inc.
|
| Application Type |
Initial (Variation)
|
| Issuance Date |
04 October 2022
|
| Expiry Date |
04 October 2027
|